explore -WSS

explore

author：fashion 2025-09-30 23:40:39 - browse：66446

Truvian Health employee with a plate holding reagents used to measure commonly tested blood markers. Truvian

SAN DIEGO — Truvian Health, a San Diego blood diagnostics company, shared data on Tuesday showing that its benchtop instrument’s results are largely consistent with those generated by large central laboratories. But while the results lend support for the company’s vision of decentralized and widely available clinical testing, they also resurface questions about the value of an approach widely associated with the now defunct and notorious Bay Area startup Theranos.

In a multisite study, the company tested nearly 240 blood samples from healthy donors and chronic disease patients for dozens of blood-based measurements commonly ordered by doctors, from cholesterol to blood sugar to blood cell counts. Results from Truvian’s benchtop analytical instrument, with few exceptions, closely matched readings from devices used in large central labs and made by Swiss pharma giant Roche and Japanese firm Sysmex.

The findings were presented at the annual meeting of the American Association for Clinical Chemistry, recently rebranded as the Association for Diagnostics & Laboratory Medicine. It’s the first time Truvian has shared clinical data on its product, though they have not been published in a peer-reviewed journal. The company, which is planning additional validation studies, expects to submit for Food and Drug Administration approval of its device by the third quarter of 2024.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Shingles, which affected Dianne Feinstein, is on the rise

leisure time

WSS

Ionis has late

Covid vaccines: Private market messier than government rollout

Beware reading your test results before your doctor does

Intercept Pharmaceuticals sells itself for less than $1 billion

Intercept Pharmaceuticals sells itself for less than $1 billion

Archived: an online chat discussing Ebola, vaccines, and a new epidemic

hotspot

explore

hotspot

How one medical school became remarkably diverse

AstraZeneca lung cancer study comes in below expectations

Drug repurposing or repositioning? The language matters

Kaiser Permanente unions announce official strike date

Jerome Adams on the need for new antivirals for Covid

Inequities make cancer less preventable for women: report

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Skip the lead apron during X

Malaria cases in Florida and Texas: Here’s what you need to know

Crowdfunding for unproven stem cell procedures spreads misinformation

entertainment

Canadians with cystic fibrosis outlive Americans by a decade

After a drawn out lobbying fight, ARPA

Beware reading your test results before your doctor does

Security flaws in third

After a drawn out lobbying fight, ARPA

Archived: an online chat discussing Ebola, vaccines, and a new epidemic

leisure time

focus

explore

explore